DE69912988D1 - Verwendung eines serinproteaseinhibitors vom kunitz-typ zur beschleunigung der schleimauflöserate - Google Patents

Verwendung eines serinproteaseinhibitors vom kunitz-typ zur beschleunigung der schleimauflöserate

Info

Publication number
DE69912988D1
DE69912988D1 DE69912988T DE69912988T DE69912988D1 DE 69912988 D1 DE69912988 D1 DE 69912988D1 DE 69912988 T DE69912988 T DE 69912988T DE 69912988 T DE69912988 T DE 69912988T DE 69912988 D1 DE69912988 D1 DE 69912988D1
Authority
DE
Germany
Prior art keywords
kunitz
slime
accelerate
inhibitor
resolution rate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69912988T
Other languages
English (en)
Other versions
DE69912988T2 (de
Inventor
Roderick Hall
Christopher T Poll
Benjamin B Newton
William J A Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of DE69912988D1 publication Critical patent/DE69912988D1/de
Application granted granted Critical
Publication of DE69912988T2 publication Critical patent/DE69912988T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
DE69912988T 1998-12-22 1999-12-22 Verwendung eines serinproteaseinhibitors vom kunitz-typ zur beschleunigung der schleimauflöserate Expired - Fee Related DE69912988T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US441966 1982-11-15
US21891398A 1998-12-22 1998-12-22
US218913 1998-12-22
US44196699A 1999-11-17 1999-11-17
PCT/GB1999/004381 WO2000037099A2 (en) 1998-12-22 1999-12-22 Method for accelerating the rate of mucociliary clearance by using a kunitz-type serine protease inhibitor

Publications (2)

Publication Number Publication Date
DE69912988D1 true DE69912988D1 (de) 2003-12-24
DE69912988T2 DE69912988T2 (de) 2004-11-11

Family

ID=26913378

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69912988T Expired - Fee Related DE69912988T2 (de) 1998-12-22 1999-12-22 Verwendung eines serinproteaseinhibitors vom kunitz-typ zur beschleunigung der schleimauflöserate
DE69939559T Expired - Fee Related DE69939559D1 (de) 1998-12-22 1999-12-22 Methode zur Beschleunigung der Schleimauflöserate

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69939559T Expired - Fee Related DE69939559D1 (de) 1998-12-22 1999-12-22 Methode zur Beschleunigung der Schleimauflöserate

Country Status (13)

Country Link
US (1) US20070086956A1 (de)
EP (2) EP1140150B1 (de)
JP (2) JP3819239B2 (de)
CN (1) CN1229138C (de)
AR (1) AR030257A1 (de)
AT (2) ATE407694T1 (de)
AU (1) AU758832B2 (de)
CA (1) CA2356404C (de)
DE (2) DE69912988T2 (de)
DK (2) DK1374891T3 (de)
ES (2) ES2318075T3 (de)
TW (1) TWI249406B (de)
WO (1) WO2000037099A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7244616B2 (en) 2003-06-27 2007-07-17 Bayer Pharmaceuticals Corporation Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells
CN1332715C (zh) * 2003-09-09 2007-08-22 王继峰 蛋白酶抑制剂在制备预防和治疗肺部疾病的药物中的用途
EP1586587A1 (de) * 2004-04-16 2005-10-19 Exonhit Therapeutics SA Zusammensetzungen und Verfahren zum Nachweis der Angiogenese
GB0411145D0 (en) * 2004-05-19 2004-06-23 Imp College Innovations Ltd Protease inhibitors and their therapeutic applications
CN100408094C (zh) * 2005-08-29 2008-08-06 吉林圣元科技有限责任公司 蛋白酶抑制剂在保护肝细胞功能中的应用
AU2007297691B2 (en) * 2006-09-19 2013-12-19 Discovery Laboratories, Inc. Pulmonary surfactant formulations and methods for promoting mucus clearance
WO2013175007A1 (en) * 2012-05-25 2013-11-28 Inserm Agents for treating cystic fibrosis
JP2016204360A (ja) * 2015-02-25 2016-12-08 エー１エム ファーマ エービーＡ１Ｍ Ｐｈａｒｍａ ＡＢ 放射性核種療法における腎臓の保護に用いるためのアルファ−１−ミクログロブリン

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223482A (en) * 1986-11-17 1993-06-29 Scios Nova Inc. Recombinant Alzheimer's protease inhibitory amyloid protein and method of use
US5106833A (en) * 1987-07-23 1992-04-21 Washington University Coagulation inhibitors
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5663143A (en) * 1988-09-02 1997-09-02 Dyax Corp. Engineered human-derived kunitz domains that inhibit human neutrophil elastase
ES2066033T3 (es) * 1989-05-13 1995-03-01 Bayer Ag Inhibidores de las proteinasas, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
DK408089D0 (da) * 1989-08-18 1989-08-18 Novo Nordisk As Proteiner
DE573603T1 (de) * 1991-03-01 1999-05-06 Dyax Corp Hemmstoffe für menschliche neutrophile elastase und menschliches kathepsin g.
RU2054180C1 (ru) * 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций
IL104325A (en) * 1992-01-07 2000-10-31 Novo Nordisk As Variants of human kunitz-type protease inhibitor domain II of tissue factor pathway inhibitor (TFPI) pharmaceutical compositions containing them a DNA construct encoding them their expression vectors a cell containing said DNA constructs and methods for the production of all the above
WO1994001461A1 (en) * 1992-07-13 1994-01-20 Corvas International, Inc. BOVINE PANCREATIC TRYPSIN INHIBITOR DERIVED INHIBITORS OF FACTOR Xa
US5436153A (en) * 1992-12-02 1995-07-25 Sprecher; Cindy A. Human amyloid protein precursor homolog and Kunitz-type inhibitor
AU5684594A (en) * 1992-12-02 1994-06-22 Novo Nordisk A/S Novel human amyloid protein precursor homologue and kunitz-type inhibitors
JP2769083B2 (ja) * 1993-02-22 1998-06-25 日清食品株式会社 エラスターゼ阻害活性を有する新規ペプチドおよびその製造方法
US5455338A (en) * 1993-11-05 1995-10-03 Zymogenetics, Inc. DNA encoding novel human kunitz-type inhibitors and methods relating thereto
WO1995021601A2 (en) * 1994-01-11 1995-08-17 Protein Engineering Corporation Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
US5795954A (en) * 1994-03-04 1998-08-18 Genentech, Inc. Factor VIIa inhibitors from Kunitz domain proteins
US5786328A (en) * 1995-06-05 1998-07-28 Genentech, Inc. Use of kunitz type plasma kallikrein inhibitors
EP0758682B1 (de) * 1995-07-24 2004-05-12 Mitsubishi Chemical Corporation Inhibitor des Hepatozytwachstumsfaktoraktivators
US5736364A (en) * 1995-12-04 1998-04-07 Genentech, Inc. Factor viia inhibitors
HU226419B1 (en) * 1996-03-11 2008-12-29 Aerovance Human bikunin
US20070140979A1 (en) * 1998-12-22 2007-06-21 Bayer Aktiengesellschaft Method for accelerating the rate of mucociliary clearance

Also Published As

Publication number Publication date
DK1140150T3 (da) 2004-03-22
TWI249406B (en) 2006-02-21
DE69912988T2 (de) 2004-11-11
CN1334743A (zh) 2002-02-06
AU1987800A (en) 2000-07-12
CA2356404A1 (en) 2000-06-29
ES2318075T3 (es) 2009-05-01
EP1374891A1 (de) 2004-01-02
JP2006232810A (ja) 2006-09-07
DK1374891T3 (da) 2009-01-26
EP1374891B1 (de) 2008-09-10
AR030257A1 (es) 2003-08-20
CN1229138C (zh) 2005-11-30
JP3819239B2 (ja) 2006-09-06
ATE254473T1 (de) 2003-12-15
EP1140150A2 (de) 2001-10-10
DE69939559D1 (de) 2008-10-23
ES2209542T3 (es) 2004-06-16
CA2356404C (en) 2010-03-30
JP2002532558A (ja) 2002-10-02
US20070086956A1 (en) 2007-04-19
EP1140150B1 (de) 2003-11-19
WO2000037099A2 (en) 2000-06-29
WO2000037099A3 (en) 2000-10-26
ATE407694T1 (de) 2008-09-15
AU758832B2 (en) 2003-04-03

Similar Documents

Publication Publication Date Title
DE60109943D1 (de) Inhibitoren der durch alpha 4 vermittelten zelladhäsion
NO20011966D0 (no) Serin-protease-inhibitor
EE200000386A (et) Aspartüülproteaasi inhibiitorite eelravimid
DE69623298D1 (de) Tetrahydrofuranyl (thf) enthaltende sulfonamidinhibitoren der aspartyl-protease
DE69312901D1 (de) Naphtensäurekorrosionsschutzmittel
ATE219057T1 (de) Bisulfatsalz eines hiv-protease-inhibitors
DE50004965D1 (de) Inhibitorkomposition zur Stabilisierung von radikalisch polymerisierbaren Substanzen
ATE414129T1 (de) Nicht-karzinogene zusammensetzung für korrosionshemmung
DE60227776D1 (de) Verfahren zur vorhersage der einströmenden abwassermenge
DE69912988D1 (de) Verwendung eines serinproteaseinhibitors vom kunitz-typ zur beschleunigung der schleimauflöserate
DE69705898D1 (de) Verwendung eines Tensidgemisches zur Korrosionsinhibierung
DE59810597D1 (de) Verfahren zur ermittlung des ortes einer teilentladung
DK0974555T3 (da) Fremgangsmåde til syntese af aluminaer i et basisk medium
NO20005826D0 (no) Bionedbrytbare korrosjonsinhibitorer
NO975073D0 (no) Lavtoksisk korrosjonshemmer
DE69330315T2 (de) Neues bowman-birk inhibitorprodukt zur verwendung als antikrebsmittel
DE69913060D1 (de) Verfahren zur Behandlung eines Resists
DE29801934U1 (de) Vorrichtung zur Strahlreinigung eines Abwasser enthaltenden Beckens
ATE224350T1 (de) Inhibition der matrix metalloproteasen durch 2- (omega-aroylalkyl)-4-biaryl-4-oxobutansäuren
DE59501723D1 (de) Verfahren zum digitalen bestimmen des effektivwertes eines periodischen elektrischen messsignals
DE59303002D1 (de) Vorrichtung zur Herstellung eines Betonrohres
DE60102399D1 (de) Verfahren zur Herstellung von 5'-Nor-anhydrovinblastinditartrat aus Pflanzen der Gattung Catharanthus
DE29720912U1 (de) Vorrichtung zur Überwachung des Kontaktabbrands eines Kontaktstücks
DE9406255U1 (de) Anordnung zur Gewinnung kleiner Mengen reinen Wassers
DE69407003D1 (de) Anlage zur kontinuierlichen Reinigung vom Lösungsmittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee